Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03005041 · ClinicalTrials.gov registry record · NA
Consumer Perception of an Experimental Mouthwash After a Single Use in Dry Mouth Subjects
A NA study of Xerostomia, sponsored by GlaxoSmithKline.
- Completed
- Registry status
- NA
- Development phase
- 56
- Enrollment target
- 1
- Study location
NCT03005041: Completed NA study of Xerostomia, sponsored by GlaxoSmithKline.
NCT03005041 is a NA study of Xerostomia that has completed, run by GlaxoSmithKline. The registered enrollment target is 56 participants, below the 91-participant average among 13 other Xerostomia trials with a reported enrollment target (38% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT03005041, a NA study of Xerostomia, has completed, sponsored by GlaxoSmithKline.
- COMPLETED
- Registry status
- NA
- Development phase
- 56 participants
- Enrollment target
- 1
- Study location
Study Summary
The purpose of this study is to investigate the consumer perception of an experimental mouthwash formulation in population with dry mouth
Primary Outcome
Participants answered the following question, Q1: how much do you agree or disagree with the following statements about this product, having used it? "This product is gentle": disagree strongly, disagree, neither agree nor disagree, agree, or agree strongly. There was no formal statistical hypothesis to be tested for this outcome..
Conditions Studied
Interventions
- OTHER Biotene mouthwash
- OTHER Bottled mineral water
Study Locations (1)
Massachusetts
- GSK Investigational Site - Boston
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 56 participants |
| Start Date | 2016-08-31 |
| Est. Completion | 2016-10-19 |
| Phase | NA |
What the finished NCT03005041 record still lists
NCT03005041 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 56 participants, a relatively small participant target, below the 91-participant average among 13 other Xerostomia trials with a reported enrollment target (38% lower).
The record links to 1 condition, with Xerostomia appearing as the primary indexed condition, and to 2 interventions - of which Biotene mouthwash is the first listed.
NCT03005041 reports a single indexed study location in Massachusetts.
Frequently Asked Questions
What is clinical trial NCT03005041 about?
NCT03005041 is a clinical study titled "Consumer Perception of an Experimental Mouthwash After a Single Use in Dry Mouth Subjects". The purpose of this study is to investigate the consumer perception of an experimental mouthwash formulation in population with dry mouth
What is the current status of trial NCT03005041?
This trial is currently completed. It is a NA study. The enrollment target is 56 participants. The study started on 2016-08-31. Estimated completion is 2016-10-19.
What conditions does trial NCT03005041 study?
This clinical trial studies the following conditions: Xerostomia.
What interventions are being tested in trial NCT03005041?
The interventions under investigation include: Biotene mouthwash (OTHER), Bottled mineral water (OTHER).
Who is sponsoring clinical trial NCT03005041?
This trial is sponsored by GlaxoSmithKline, which has 1,345 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT03005041 being conducted?
This trial has 1 study location across Massachusetts. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Xerostomia
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT03005041's enrollment target sits among peer trials
56 6th of 13 higher than 8 of 13 other Xerostomia trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Xerostomia trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Effect of Whitening Agent With Emulsion Gel in Saliva and Halitosis
ACTIVE NOT RECRUITING · NA
-
SaliPen Human Factors Study for OTC Labeling
COMPLETED · NA
-
Potential of an Experimental Mouthwash Formulation to Reduce Dry Mouth Symptoms
COMPLETED · NA
-
Evaluation of the Efficacy of 3M Dry Mouth Moisturizing Spray
COMPLETED · NA
-
d-Limonene +Radiation +PlatinumBasedChemo for Xerostomia Prevention in LocallyAdvanced HNSCC
RECRUITING · Phase 1
-
Dose-Escalation Trial of Mesenchymal Stromal Cells in Patients With Medical Xerostomia
RECRUITING · Phase 1
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02287428 · 56 participants · Phase 1
Personalized NeoAntigen Cancer Vaccine w RT Plus Pembrolizumab for Patients With Newly Diagnosed GBM
- NCT02923011 · 56 participants · Phase 3
Comparative Effectiveness of MRgFUS Versus CTgRFA for Osteoid Osteomas
- NCT02935283 · 56 participants
Neuroimaging and Neuropsychological Outcomes in Urea Cycle Disorders
- NCT03375866 · 56 participants · NA
Effects of Mixed Nut Consumption on Satiety and Weight Management
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI